Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease
- 1 April 1999
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 265 (3) , 155-158
- https://doi.org/10.1016/s0304-3940(99)00221-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Increased plasma lipid peroxidation in patients with aceruloplasminemiaFree Radical Biology & Medicine, 1996
- Depletion of Copper and Manganese in Brain after MPTP Treatment of MiceBasic & Clinical Pharmacology & Toxicology, 1995
- Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a japanese familyAnnals of Neurology, 1995
- Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?Journal of Neurochemistry, 1994
- Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+European Journal of Pharmacology: Molecular Pharmacology, 1994
- New insights into the cause of Parkinson's diseaseNeurology, 1992
- Deficiency of copper can cause neuronal degenerationMedical Hypotheses, 1992
- RAISED CEREBROSPINAL-FLUID COPPER CONCENTRATION IN PARKINSON'S DISEASEPublished by Elsevier ,1987
- A new method for assay of ferroxidase activity and its application to human and rabbit sera.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- ParkinsonismNeurology, 1967